Dariusz Mirosław Kowalski

26PUBLICATIONS
116CO-AUTHORS
Memory and attentionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 10, 2026
Reply to: "Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743" and "Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743".

|Jun 03, 2026
Participant-Reported Preference for Pembrolizumab Administered Subcutaneously or Intravenously: A Randomized, Open-Label, Phase II Study.

|Feb 24, 2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.

Arnaud Scherpereel, Paul Baas, Anna K Nowak

|Dec 30, 2025
Clinicopathologic Characteristics, Treatment Outcomes, and Survival in Thymic Neuroendocrine Neoplasms (t-NEN): A 25-Year Single-Center Experience.

Aleksandra Piórek, Adam Płużański, Dariusz M Kowalski

|Nov 26, 2025
Radiation Recall Pneumonitis with Pneumocystis jirovecii Superinfection and Treatment Induced Hyponatremia in a Patient with Non-Small-Cell Lung Cancer.

Aleksandra Piórek, Adam Płużański, Dariusz M Kowalski

|Nov 13, 2025
Best Practices and Communication Strategies for Informing Oncology Patients About Treatment Discontinuation and Transition to Palliative Care-A Practical Guide for Oncologists.

Aleksandra Piórek, Adam Płużański, Dariusz M Kowalski

Pageof 5

Frequent Collaborators

8 joint publications

Adam Płużański

7 joint publications

Aleksandra Piórek

6 joint publications

Magdalena Knetki-Wróblewska

6 joint publications

Maciej Krzakowski